These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 17367357)

  • 1. Impact of renal function on survival in patients with implantable cardioverter-defibrillators.
    Turakhia MP; Varosy PD; Lee K; Tseng ZH; Lee R; Badhwar N; Scheinman M; Lee BK; Olgin JE
    Pacing Clin Electrophysiol; 2007 Mar; 30(3):377-84. PubMed ID: 17367357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic renal insufficiency is an independent predictor of mortality in implantable cardioverter-defibrillator recipients.
    Chen-Scarabelli C; Scarabelli TM
    Pacing Clin Electrophysiol; 2007 Mar; 30(3):371-6. PubMed ID: 17367356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis.
    Nakhoul GN; Schold JD; Arrigain S; Harb SC; Jolly S; Wilkoff BL; Nally JV; Navaneethan SD
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1119-27. PubMed ID: 26111859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Outcomes With Cardiac Resynchronization Therapy in Patients With Mild Heart Failure With Moderate Renal Dysfunction.
    Daimee UA; Moss AJ; Biton Y; Solomon SD; Klein HU; McNitt S; Polonsky B; Zareba W; Goldenberg I; Kutyifa V
    Circ Heart Fail; 2015 Jul; 8(4):725-32. PubMed ID: 26038537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival after primary prevention implantable cardioverter-defibrillator placement among patients with chronic kidney disease.
    Hess PL; Hellkamp AS; Peterson ED; Sanders GD; Al-Khalidi HR; Curtis LH; Hammill BG; Pun PH; Curtis JP; Anstrom KJ; Hammill SC; Al-Khatib SM
    Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):793-9. PubMed ID: 25038119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival and long-term cardiovascular outcomes after carotid endarterectomy in patients with chronic renal insufficiency.
    Avgerinos ED; Go C; Ling J; Makaroun MS; Chaer RA
    Ann Vasc Surg; 2015 Jan; 29(1):15-21. PubMed ID: 25194551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of advanced age on survival in patients with implantable cardioverter defibrillators.
    Pellegrini CN; Lee K; Olgin JE; Turakhia MP; Tseng ZH; Lee R; Badhwar N; Lee B; Varosy PD
    Europace; 2008 Nov; 10(11):1296-301. PubMed ID: 18818212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical markers of organ dysfunction associated with increased 1-year mortality post-implantable cardioverter defibrillator implantation.
    Chong D; Tan BY; Ho KL; Liew R; Teo WS; Ching CK
    Europace; 2013 Apr; 15(4):508-14. PubMed ID: 22848076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillators.
    Bansal N; Szpiro A; Masoudi F; Greenlee RT; Smith DH; Magid DJ; Gurwitz JH; Reynolds K; Tabada GH; Sung SH; Dighe A; Cassidy-Bushrow A; Garcia-Montilla R; Hammill S; Hayes J; Kadish A; Sharma P; Varosy P; Vidaillet H; Go AS
    Heart; 2017 Apr; 103(7):529-537. PubMed ID: 27742796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal function impairment predicts mortality in patients with chronic heart failure treated with resynchronization therapy.
    Gronda E; Genovese S; Padeletti L; Cacciatore F; Vitale DF; Bragato R; Innocenti L; Schiano C; Sommese L; De Pascale MR; Genovese L; Abete P; Donatelli F; Napoli C
    Cardiol J; 2015; 22(4):459-66. PubMed ID: 26325259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death.
    Cuculich PS; Sánchez JM; Kerzner R; Greenberg SL; Sengupta J; Chen J; Faddis MN; Gleva MJ; Smith TW; Lindsay BD
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):207-13. PubMed ID: 17338717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of death without appropriate defibrillator shock in patients with advanced renal dysfunction.
    Goldenberg I; Mor T; Nof E; Younis A; Berkovitch A; Rosso R; Barsheshet A; Suleiman M; Beinart R
    Europace; 2019 Mar; 21(3):459-464. PubMed ID: 30689821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of chronic renal insufficiency by use of glomerular filtration rate versus serum creatinine level on late clinical outcome of carotid endarterectomy.
    AbuRahma AF; Srivastava M; Stone PA; Chong B; Jackson W; Dean LS; Mousa AY
    J Vasc Surg; 2015 Mar; 61(3):675-82. PubMed ID: 25499714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of gender on mortality or appropriate shock in patients with nonischemic cardiomyopathy who have implantable cardioverter-defibrillators.
    Chen HA; Hsia HH; Vagelos R; Fowler M; Wang P; Al-Ahmad A
    Pacing Clin Electrophysiol; 2007 Mar; 30(3):390-4. PubMed ID: 17367359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do implantable cardioverter defibrillators improve survival in patients with chronic kidney disease at high risk of sudden cardiac death? A meta-analysis of observational studies.
    Makki N; Swaminathan PD; Hanmer J; Olshansky B
    Europace; 2014 Jan; 16(1):55-62. PubMed ID: 24058182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Chronic Kidney Disease on Mortality with Cardiac Resynchronization Therapy.
    Daly DD; Maran A; Hyer JM; Funke F; Waring A; Cuoco FA; Sturdivant JL; Leman RB; Gold MR
    Pacing Clin Electrophysiol; 2016 Aug; 39(8):863-9. PubMed ID: 27197959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival and Functional Stability in Chronic Kidney Disease Due to Surgical Removal of Nephrons: Importance of the New Baseline Glomerular Filtration Rate.
    Lane BR; Demirjian S; Derweesh IH; Takagi T; Zhang Z; Velet L; Ercole CE; Fergany AF; Campbell SC
    Eur Urol; 2015 Dec; 68(6):996-1003. PubMed ID: 26012710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention.
    Chan PS; Nallamothu BK; Spertus JA; Masoudi FA; Bartone C; Kereiakes DJ; Chow T
    Circ Cardiovasc Qual Outcomes; 2009 Jan; 2(1):16-24. PubMed ID: 20031808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable cardioverter defibrillator therapy in chronic kidney disease: a meta-analysis.
    Korantzopoulos P; Liu T; Li L; Goudevenos JA; Li G
    Europace; 2009 Nov; 11(11):1469-75. PubMed ID: 19812050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of renal dysfunction on appropriate therapy in implantable cardioverter defibrillator patients with non-ischaemic dilated cardiomyopathy.
    Takahashi A; Shiga T; Shoda M; Manaka T; Ejima K; Hagiwara N
    Europace; 2009 Nov; 11(11):1476-82. PubMed ID: 19661116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.